Evidence Based Treatments of Alopecia Areata

    December 2022
    Ahmed Hamza Al-Shammari, Qusay Jassam Shandookh
    Image of study
    TLDR Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.
    Androgenetic Alopecia (AGA) is a major non-cicatricial alopecia that causes progressive hair follicle miniaturization, largely determined by a person's genetic makeup and hormonal environment. It is characterized by a shortening of the anagen phase and maintenance of the telogen phase. Females with AGA typically experience more diffuse hair loss over the head, while males usually see thinning near the vertex. The only FDA-approved treatments for AGA are minoxidil (used topically) and finasteride (an oral 5α-reductase inhibitor type II inhibitor). However, the effectiveness of these treatments is often questioned, highlighting the need for new therapeutics. This article aims to examine the causes and diagnostic tools used to identify AGA, in order to improve disease outcomes.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community My scalp punch biopsy results🤔?

      in Female  8 upvotes 1 year ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community AGA evaluation and first steps - BEGINNER MEGAPOST

      in Chat  73 upvotes 2 months ago
      The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    10 / 10 results